Cloned human inward rectifier K+ channel as a target for class III methanesulfonanilides.
Cloned human inward rectifier K+ channel as a target for class III methanesulfonanilides.
复制标题
克隆的人类内向整流 K 通道作为 III 类甲磺酰苯胺的靶标。
DOI:
10.1161/01.res.77.6.1151
复制
发表时间:
1995
影响因子:
20.1
通讯作者:
Brown,AM
中科院分区:
文献类型:
--
作者:
Kiehn,J;Wible,B;Ficker,E;Taglialatela,M;Brown,AM
Methanesulfonanilide derivatives such as dofetilide are members of the widely used Class III group of cardiac antiarrhythmic drugs. A methanesulfonanilide-sensitive cardiac current has been identified as IKr, the rapidly activating component of the repolarizing outward cardiac K+current, IK. IKrmay be encoded by the human ether-related gene (hERG), which belongs to the family of voltage-dependent K+(Kv) channels having six putative transmembrane segments. The hERG also expresses an inwardly rectifying, methanesulfonanilide-sensitive K+current. Here we show that hIRK, a member of the two-transmembrane-segment family of inward K+rectifiers that we have cloned from human heart, is a target for dofetilide. hIRK currents, expressed heterologously inXenopusoocytes, are blocked by dofetilide at submicromolar concentrations (IC50=533 nmol/L at 40 mV and 20°C). The drug has no significant blocking effect on the human cardiac Kvchannels hKv1.2, hKv1.4, hKv1.5, or hKv2.1. The block is voltage dependent, use dependent, and shortens open times in a manner consistent with open-channel block. While steady state block is strongest at depolarized potentials, recovery from block is very slow even at hyperpolarized potentials (tau=1.17 seconds at −80 mV). Thus, block of hIRK may persist during diastole and might thereby affect cardiac excitability.